BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11588015)

  • 1. Type II pneumocyte-CD8+ T-cell interactions. Relationship between target cell cytotoxicity and activation.
    Zhao MQ; Amir MK; Rice WR; Enelow RI
    Am J Respir Cell Mol Biol; 2001 Sep; 25(3):362-9. PubMed ID: 11588015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
    Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI
    Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition.
    Zhao MQ; Stoler MH; Liu AN; Wei B; Soguero C; Hahn YS; Enelow RI
    J Clin Invest; 2000 Sep; 106(6):R49-58. PubMed ID: 10995793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for tumor necrosis factor-receptor 2 in alveolar chemokine expression depends upon the form of the ligand.
    Liu J; Zhao MQ; Xu L; Ramana CV; Declercq W; Vandenabeele P; Enelow RI
    Am J Respir Cell Mol Biol; 2005 Nov; 33(5):463-9. PubMed ID: 16081883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung epithelial NF-kappaB and Stat1 signaling in response to CD8+ T cell antigen recognition.
    Ramana CV; Chintapalli J; Xu L; Alia C; Zhou J; Bruder D; Enelow RI
    J Interferon Cytokine Res; 2006 May; 26(5):318-27. PubMed ID: 16689660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells.
    Slifka MK; Rodriguez F; Whitton JL
    Nature; 1999 Sep; 401(6748):76-9. PubMed ID: 10485708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity.
    Lin X; Pease LR; Murray PD; Rodriguez M
    J Immunol; 1998 Jun; 160(11):5661-8. PubMed ID: 9605173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.
    Johnson BJ; Costelloe EO; Fitzpatrick DR; Haanen JB; Schumacher TN; Brown LE; Kelso A
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2657-62. PubMed ID: 12601154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential requirement of perforin and IFN-gamma in CD8 T cell-mediated immune responses against B16.F10 melanoma cells expressing a viral antigen.
    Prévost-Blondel A; Neuenhahn M; Rawiel M; Pircher H
    Eur J Immunol; 2000 Sep; 30(9):2507-15. PubMed ID: 11009083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic alterations in type II alveolar epithelial cells in CD4+ T cell mediated lung inflammation.
    Gereke M; Gröbe L; Prettin S; Kasper M; Deppenmeier S; Gruber AD; Enelow RI; Buer J; Bruder D
    Respir Res; 2007 Jul; 8(1):47. PubMed ID: 17610738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8(+) T cells responding to alveolar self-antigen lack CD25 expression and fail to precipitate autoimmunity.
    Tosiek MJ; Bader SR; Gruber AD; Buer J; Gereke M; Bruder D
    Am J Respir Cell Mol Biol; 2012 Dec; 47(6):869-78. PubMed ID: 22984087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes.
    Topham DJ; Tripp RA; Doherty PC
    J Immunol; 1997 Dec; 159(11):5197-200. PubMed ID: 9548456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A11 Tetramer-assisted characterization of Rta-specific CD8+ T-cell responses in healthy virus carriers.
    Yu HX; Srinivasan N; Ren EE; Chan SH
    Tissue Antigens; 2005 Jun; 65(6):539-43. PubMed ID: 15896201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells.
    Scherle PA; Palladino G; Gerhard W
    J Immunol; 1992 Jan; 148(1):212-7. PubMed ID: 1530795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perforin-deficient CD8+ T cells: in vivo priming and antigen-specific immunity against Listeria monocytogenes.
    White DW; MacNeil A; Busch DH; Pilip IM; Pamer EG; Harty JT
    J Immunol; 1999 Jan; 162(2):980-8. PubMed ID: 9916723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
    Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
    J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells.
    Williams NS; Engelhard VH
    J Immunol; 1997 Sep; 159(5):2091-9. PubMed ID: 9278294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
    Arancia G; Malorni W; Donelli G
    Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
    J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.